Symposium Pediatric ADHD: Optimizing symptom control & functioning after methylphenidate

Learning objectives:

1. Improve knowledge and awareness on the possibilities to optimize symptom control and functioning in pediatric ADHD
   1. Focus on updates of NICE and CADDRA guideline: what has changed?
       
2. Discuss pharmacological treatment options for the treatment of pediatric ADHD after methylphenidate in line with treatment guidelines in the Netherlands and abroad
   1. Focus on treatment options after methylphenidate
      1. When to switch to dexamphetamine? Why try another stimulant?
      2. When to switch to a non-stimulant?
      3. How do the available treatment options compare in efficacy and safety?
          
3. Improve knowledge on the available data on pharmacological treatment of pediatric ADHD
   1. What data is available on symptom control and functional improvement for dexamphetamine, atomoxetine and guanfacine? How to interpret these data in clinical practice?